Clinical

Dataset Information

0

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver


ABSTRACT: Patients with unresectable metastatic colorectal cancer confined to the liver will undergo a 1 hour hyperthermic isolated hepatic perfusion (IHP) with escalating dose melphalan. Postoperatively, patients will be treated with hepatic arterial infusion of floxuridine (FUDR), 0.2 mg/kg/day and leucovorin (LV), 15 mg/M2/day as a 2-week continuous infusion regimen. Hepatic and systemic toxicity, response to treatment, duration of response, and survival will be followed.

DISEASE(S): Neoplasm Metastasis,Colorectal Neoplasm,Colorectal Neoplasms,Liver Neoplasms,Liver Neoplasm,Neoplasms

PROVIDER: 2001372 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2011729 | ecrin-mdr-crc
2011-01-01 | GSE22968 | GEO
2011-01-01 | E-GEOD-22968 | biostudies-arrayexpress
2024-04-01 | GSE225899 | GEO
2008-11-07 | E-GEOD-8615 | biostudies-arrayexpress
| 2043683 | ecrin-mdr-crc
2020-07-17 | PXD019725 | Pride
| 2011251 | ecrin-mdr-crc
2011-12-13 | E-GEOD-34381 | biostudies-arrayexpress
2015-05-26 | PXD001276 | Pride